The chicken anemia virus-derived protein Apoptin induces apoptosis in a variety of human malignant and transformed cells but not in normal cells. However, the mechanisms through which Apoptin achieves its selective killing effects are not well understood. We developed a 
was added to the cell lysate with antibody for 2-3 hours at 4 o C and complexes were pulled-down using a magnet rack.
Proteins from different fractions of the cell were isolated using the ProteoJET cytoplasmic and nuclear protein extraction kit (Fermentas, UK, K0311) according to the manufacturer's protocol.
For Western blotting, the proteins were separated on SDS-PAGE gels; electroblotted onto nitrocellulose membrane (GE Healthcare, UK) and blocked with 5% non-fat dried milk for 1hour
at room temperature. The membrane was incubated with a specific primary antibody and a horseradish peroxidase-conjugated secondary antibody and developed using an enhanced chemiluminescent detection system and exposed to ECL film (both Amersham Biosciences, UK).
The blot was stripped with ReBlot plus strong antibody stripping buffer (Millipore, UK) and reprobed with a different antibody as required.
Antibodies against Thr-108 phosphorylated Apoptin or total Apoptin were raised in rabbit against peptides, H2N-SLITTT(PO3H2)PSRPRTA-CONH2, H2N-SLITTTPSRPRTA-CONH2
respectively (Eurogentec, Belgium). All antibodies used in the study were purchased from Santa
Cruz Biotechnology except antibodies against MERTK, DGKH, and GFP for immunoprecipitation which were purchased from Abcam and antibodies against phospho-AKTSer-473, phospho-PKCβ2-Thr-638, total AKT, PI3K/p85, caspase 3, caspase 9 and GFP for Western blotting were purchased from Cell Signalling. 
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